These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3019595)

  • 21. Vanadate-induced inhibition of renin secretion is unrelated to inhibition Na,K-ATPase activity.
    Churchill PC; Rossi NF; Churchill MC; Ellis VR
    Life Sci; 1990; 46(26):1953-9. PubMed ID: 2163483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-II inhibits Na+/K+ pump in rat adrenal glomerulosa cells: possible contribution to stimulation of aldosterone production.
    Hajnóczky G; Csordás G; Hunyady L; Kalapos MP; Balla T; Enyedi P; Spät A
    Endocrinology; 1992 Mar; 130(3):1637-44. PubMed ID: 1311245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of rat brain microsomal Na+/K(+)-ATPase and ouabain binding by mercuric chloride.
    Chetty CS; Rajanna B; Rajanna S
    Toxicol Lett; 1990 Mar; 51(1):109-16. PubMed ID: 2156358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracerebroventricular administration of ouabain, a Na/K-ATPase inhibitor, activates mTOR signal pathways and protein translation in the rat frontal cortex.
    Kim SH; Yu HS; Park HG; Ha K; Kim YS; Shin SY; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():73-82. PubMed ID: 23643758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Na+,K+-ATPase interaction with a brain endogenous inhibitor (endobain E).
    Rodríguez de Lores Arnaiz G; Reinés A; Herbin T; Peña C
    Neurochem Int; 1998 Nov; 33(5):425-33. PubMed ID: 9874093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The kidney in potassium depletion. I. Na+-K+-ATPase activity and [3H]ouabain binding in MCT.
    Hayashi M; Katz AI
    Am J Physiol; 1987 Mar; 252(3 Pt 2):F437-46. PubMed ID: 3030136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin.
    Meyer-Lehnert H; Bäcker A; Kramer HJ
    Am J Hypertens; 2000 Apr; 13(4 Pt 1):364-9. PubMed ID: 10821337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of angiotensin-stimulated sodium transport in cultured smooth muscle cells from rat aorta.
    Smith JB; Brock TA
    J Cell Physiol; 1983 Mar; 114(3):284-90. PubMed ID: 6300146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
    Ottlecz A; Bensaoula T; Eichberg J; Peterson RG
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2157-64. PubMed ID: 8843902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of an endogenous Na+,K(+)-ATPase-specific inhibitor from pig urine.
    Tamura M; Harris TM; Konishi F; Inagami T
    Eur J Biochem; 1993 Jan; 211(1-2):317-27. PubMed ID: 8381085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site at which angiotensin II acts to stimulate ACTH secretion in vivo.
    Murakami K; Ganong WF
    Neuroendocrinology; 1987 Sep; 46(3):231-5. PubMed ID: 2821426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Will chronic intracerebroventricular saralasin infusion produce selective blockade of brain angiotensin II receptors in the rat?
    Bruner CA; Weaver JM; Fink GD
    J Pharmacol Exp Ther; 1983 Jul; 226(1):13-8. PubMed ID: 6306220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and identification of hemin as an endogenous Na+/K(+)-ATPase inhibitor from porcine blood cells.
    Yasuhara T; Mori M; Wakamatsu K; Kubo K
    Biochem Biophys Res Commun; 1991 Jul; 178(1):95-103. PubMed ID: 1648917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal actions of angiotensin-(1-7): in vivo and in vitro studies.
    Handa RK; Ferrario CM; Strandhoy JW
    Am J Physiol; 1996 Jan; 270(1 Pt 2):F141-7. PubMed ID: 8769832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of central angiotensin II receptor antagonism on fetal swallowing and cardiovascular activity.
    El-Haddad MA; Chao CR; Sayed AA; El-Haddad H; Ross MG
    Am J Obstet Gynecol; 2001 Oct; 185(4):828-33. PubMed ID: 11641660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of angiotensin II and saralasin on motor activity and the passive avoidance behavior of rats.
    Braszko JJ; Wiśniewski K
    Peptides; 1988; 9(3):475-9. PubMed ID: 3420007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physiological significance of Na+/K(+)-ATPase activity in the central nervous system and endogenous sodium-pump inhibitors in the neural regulation of arterial blood pressure.
    Shah J; Jandhyala BS
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S13-5. PubMed ID: 7508016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of an angiotensin II antagonist to influence isoprenaline-induced antidiuresis in rats.
    Greven J; Pantel J
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):271-5. PubMed ID: 3713872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete quantification of the total concentration of rat skeletal-muscle Na+ + K+-dependent ATPase by measurements of [3H]ouabain binding.
    Kjeldsen K
    Biochem J; 1986 Dec; 240(3):725-30. PubMed ID: 3030284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pressor response to CSF sodium in mice: mediation by a ouabain-like substance and renin-angiotensin system in the brain.
    Van Huysse JW; Hou X
    Brain Res; 2004 Sep; 1021(2):219-31. PubMed ID: 15342270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.